Zemplar 1 µg
Zemplar 1 µg is a medicine authorised by Swissmedic under authorisation number 57989. The authorisation holder is AbbVie AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 March 2008 and the authorisation is valid without a time limit. ATC code H05BX02 places the medicine in the group Calcium homeostasis.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zemplar 1 µg, Weichkapseln | B | 12 March 2008 |
| 2 | Zemplar 2 µg, Weichkapseln | B | 12 March 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 28 | Kapsel(n) | H05BX02 | 07.05.0. | B |
| 8 | 28 | Kapsel(n) | H05BX02 | 07.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zemplar 1 µg authorised in Switzerland?
Yes. Zemplar 1 µg is authorised by Swissmedic under authorisation number 57989, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zemplar 1 µg have?
Zemplar 1 µg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zemplar 1 µg?
The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.